Unity Biotechnology Inc. (UBX) NASDAQ

$0.59 -0.01 (-0.97%)

Market Cap: $41.10M

As of 06/24/22 04:00 PM EDT. Market closed.

(UBX)

Unity Biotechnology Inc. (UBX) NASDAQ

$0.59 -0.01 (-0.97%)

Market Cap: $41.10M

As of 06/24/22 04:00 PM EDT. Market closed.

UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic ... read more

UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Anirvan Ghosh
Full Time Employees
61
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$2.73M
URL
Address
3280 Bayshore Blvd, California, Brisbane, 94005-1028.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Anirvan Ghosh
Full Time Employees
61
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$2.73M
Address
3280 Bayshore Blvd, California, Brisbane, 94005-1028.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0.60
Previous Close
$0.60
Days Range
$0.59 - $0.63
52 week range
$0.57 - $4.97
Volume
326,341
Avg. Volume (30 days)
413,182
Market Cap
$41.10M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
69,168,939
Open
$0.60
Previous Close
$0.60
Days Range
$0.59 - $0.63
52 week range
$0.57 - $4.97
Volume
326,341
Avg. Volume (30 days)
413,182
Market Cap
$41.10M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
69,168,939

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR UNITY BIOTECHNOLOGY INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Dananberg Jamie Chief Medical Officer Jun 21, 2022 Sale $0.62 3,697 2,292 676,534 Jun 22, 2022, 04:49 PM
Ghosh Anirvan Chief Executive Officer Jun 14, 2022 Option Exercise $0.63 12,683 7,990 1,019,511 Jun 15, 2022, 04:36 PM
Dananberg Jamie Chief Medical Officer Jun 14, 2022 Option Exercise $0.63 10,530 6,634 680,231 Jun 15, 2022, 04:34 PM
Ghosh Anirvan Chief Executive Officer May 02, 2022 Option Exercise $0.88 7,729 6,802 1,032,194 May 03, 2022, 05:18 PM
Ghosh Anirvan Chief Executive Officer Mar 31, 2022 Option Exercise $1.14 14,472 16,498 1,039,923 Apr 01, 2022, 04:24 PM
Dananberg Jamie Chief Medical Officer Mar 31, 2022 Option Exercise $1.14 4,188 4,774 690,761 Apr 01, 2022, 04:24 PM
Ghosh Anirvan Chief Executive Officer Mar 14, 2022 Option Exercise $0.88 9,272 8,159 1,054,395 Mar 15, 2022, 04:54 PM
Dananberg Jamie Chief Medical Officer Mar 14, 2022 Option Exercise $0.88 10,581 9,311 694,949 Mar 15, 2022, 04:53 PM
Dananberg Jamie Chief Medical Officer Dec 14, 2021 Option Exercise $1.63 10,614 17,301 659,697 Dec 15, 2021, 04:26 PM
Dananberg Jamie Chief Medical Officer Mar 30, 2021 Option Exercise $2.95 40,564 119,664 670,311 Oct 01, 2021, 09:57 PM
Dananberg Jamie Chief Medical Officer Jun 21, 2021 Option Exercise $4.18 3,515 14,693 685,875 Jun 23, 2021, 05:03 PM
Dananberg Jamie Chief Medical Officer Mar 30, 2021 Option Exercise $5.73 2,829 16,210 689,390 Apr 01, 2021, 05:13 PM
David Nathaniel E President Dec 16, 2020 Sale $5.24 1,700,000 8,908,000 624,703 Dec 18, 2020, 05:14 PM
Goeltz II Robert C. Chief Financial Officer Jun 22, 2020 Option Exercise $9.67 2,483 24,011 161,027 Jun 24, 2020, 05:03 PM
David Nathaniel E President Jun 22, 2020 Option Exercise $9.67 2,483 24,011 2,324,703 Jun 24, 2020, 05:00 PM
Marquess Dan Chief Scientific Officer Jun 22, 2020 Option Exercise $9.67 2,483 24,011 380,690 Jun 24, 2020, 04:59 PM
Dananberg Jamie Chief Medical Officer Jun 22, 2020 Option Exercise $9.67 2,483 24,011 452,219 Jun 24, 2020, 04:59 PM
Tompkins Tamara See Remarks Jun 22, 2020 Option Exercise $9.67 2,483 24,011 42,847 Jun 24, 2020, 04:58 PM
Leonard Keith R Director Jun 22, 2020 Option Exercise $9.67 4,711 45,555 89,546 Jun 24, 2020, 04:58 PM
David Nathaniel E President Jun 05, 2020 Buy $8.90 3,200 28,478 2,327,186 Jun 09, 2020, 04:44 PM
Goeltz II Robert C. Chief Financial Officer Feb 24, 2020 Option Exercise $3.43 10,000 34,300 134,404 Feb 26, 2020, 05:48 PM
Leonard Keith R Chief Executive Officer Jun 19, 2019 Option Exercise $3.40 20,000 68,000 170,782 Jun 19, 2019, 09:14 PM
Goeltz II Robert C. Chief Financial Officer Oct 10, 2018 Option Exercise $3.43 5,000 17,150 101,348 Oct 12, 2018, 05:36 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Dananberg Jamie Chief Medical Officer 06/21/2022 2,292
Ghosh Anirvan Chief Executive Officer 06/14/2022 7,990
Dananberg Jamie Chief Medical Officer 06/14/2022 6,634
Ghosh Anirvan Chief Executive Officer 05/02/2022 6,802
Ghosh Anirvan Chief Executive Officer 03/31/2022 16,498
Dananberg Jamie Chief Medical Officer 03/31/2022 4,774
Ghosh Anirvan Chief Executive Officer 03/14/2022 8,159
Dananberg Jamie Chief Medical Officer 03/14/2022 9,311
Dananberg Jamie Chief Medical Officer 12/14/2021 17,301
Dananberg Jamie Chief Medical Officer 03/30/2021 119,664
Dananberg Jamie Chief Medical Officer 06/21/2021 14,693
Dananberg Jamie Chief Medical Officer 03/30/2021 16,210
David Nathaniel E President 12/16/2020 8,908,000
Goeltz II Robert C. Chief Financial Officer 06/22/2020 24,011
David Nathaniel E President 06/22/2020 24,011
Marquess Dan Chief Scientific Officer 06/22/2020 24,011
Dananberg Jamie Chief Medical Officer 06/22/2020 24,011
Tompkins Tamara See Remarks 06/22/2020 24,011
Leonard Keith R Director 06/22/2020 45,555
David Nathaniel E President 06/05/2020 28,478
Goeltz II Robert C. Chief Financial Officer 02/24/2020 34,300
Leonard Keith R Chief Executive Officer 06/19/2019 68,000
Goeltz II Robert C. Chief Financial Officer 10/10/2018 17,150
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
1.80%
1Q
12/31/2021
06/30/2021
2.38%
2Q
12/31/2021
03/31/2021
3.04%
3Q
12/31/2021
12/31/2020
9.73%
4Q
12/31/2021
09/30/2020
11.80%
5Q
12/31/2021
06/30/2020
14.83%
6Q
12/31/2021
12/31/2019
27.95%
8Q
12/31/2021
09/30/2019
31.07%
9Q
12/31/2021
03/31/2019
32.30%
11Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
1.80%
1Q
06/30/2021
2.38%
2Q
03/31/2021
3.04%
3Q
12/31/2020
9.73%
4Q
09/30/2020
11.80%
5Q
06/30/2020
14.83%
6Q
12/31/2019
27.95%
8Q
09/30/2019
31.07%
9Q
03/31/2019
32.30%
11Q
Load More